After a string of US projects, Thermo Fisher opens the doors to a new facility in China
Thermo Fisher recently opened a new facility in Hangzhou, China to boost biologic and sterile medicine development and add manufacturing capacity in the Asia-Pacific region.
The 80,000-square-foot facility will offer clinical and commercial drug substance and product manufacturing, including capabilities for producing cell lines, biologics and drug substances, and fill-finish abilities. The facility contains a 2,000-liter bioreactor, but in the future, it will eventually have a 5,000-liter bioreactor and a packaging area as well.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.